We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.9B
AUM Growth
-$1.92B
(-2.7%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
792
New
60
Increased
302
Reduced
281
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$761M |
| 2 |
PPG Industries
PPG
|
+$342M |
| 3 |
Pultegroup
PHM
|
+$278M |
| 4 |
Apple
AAPL
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$701M |
| 2 |
Medtronic
MDT
|
+$355M |
| 3 |
Lockheed Martin
LMT
|
+$309M |
| 4 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$286M |
| 5 |
Western Digital
WDC
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.4% |
| 2 | Technology | 13.5% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.69% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Johnson Outdoors
JOUT
$480M
| $1.93M | ﹤0.01% |
87,052
| – | – |
|
|
SCMP
627
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.91M | ﹤0.01% |
+174,554
| New | +$2.21M |
|
628
3M
MMM
$92.2B
| $1.86M | ﹤0.01% |
13,341
| – | – |
|
629
Pan American Silver
PAAS
$22.8B
| $1.84M | ﹤0.01% |
169,131
| – | – |
|
|
SHOE
630
Shoe Station Group
SHOE
$376M
| $1.83M | ﹤0.01% |
135,612
-40,288
| -23% | -$479K |
|
631
Civeo
CVEO
$349M
| $1.82M | ﹤0.01% |
123,020
-123,092
| -50% | -$1.64M |
|
632
Costamare
CMRE
$1.86B
| $1.78M | ﹤0.01% |
200,596
+45,081
| +29% | +$353K |
|
633
PC Connection
CNXN
$2.03B
| $1.78M | ﹤0.01% |
69,024
+13,349
| +24% | +$305K |
|
634
Gerdau
GGB
$9.22B
| $1.78M | ﹤0.01% |
1,260,000
-252,000
| -17% | -$224K |
|
635
Pure Cycle
PCYO
$275M
| $1.77M | ﹤0.01% |
392,885
+344,491
| +712% | +$1.55M |
|
636
DigitalBridge
DBRG
$2.99B
| $1.77M | ﹤0.01% |
39,008
+13,380
| +52% | +$591K |
|
637
Natural Gas Services Group
NGS
$457M
| $1.74M | ﹤0.01% |
80,344
-9,076
| -10% | -$173K |
|
638
Theravance Biopharma
TBPH
$885M
| $1.74M | ﹤0.01% |
+92,310
| New | +$1.51M |
|
|
CDI
639
DELISTED
CDI Corp.
CDI
| $1.71M | ﹤0.01% |
272,613
| – | – |
|
640
Wynn Resorts
WYNN
$9.64B
| $1.69M | ﹤0.01% |
+18,099
| New | +$1.34M |
|
641
Babcock & Wilcox
BW
$1.14B
| $1.68M | ﹤0.01% |
7,834
| – | – |
|
|
CCRN
642
DELISTED
Cross Country Healthcare
CCRN
| $1.67M | ﹤0.01% |
+143,530
| New | +$1.82M |
|
643
Ducommun
DCO
$2.78B
| $1.65M | ﹤0.01% |
108,430
+11,050
| +11% | +$160K |
|
644
Trip.com Group
TCOM
$28.1B
| $1.63M | ﹤0.01% |
+36,744
| New | +$1.54M |
|
645
ArcBest
ARCB
$3.11B
| $1.61M | ﹤0.01% |
74,500
| – | – |
|
646
BGC Group
BGC
$5.75B
| $1.59M | ﹤0.01% |
273,293
| – | – |
|
|
HWCC
647
DELISTED
Houston Wire & Cable Company
HWCC
| $1.54M | ﹤0.01% |
220,046
| – | – |
|
|
ALSK
648
DELISTED
Alaska Communications Systems
ALSK
| $1.52M | ﹤0.01% |
852,866
| – | – |
|
|
TARO
649
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.51M | ﹤0.01% |
10,572
| – | – |
|
650
Grupo Aeroportuario del Sureste
ASR
$7.8B
| $1.5M | ﹤0.01% |
10,000
-5,000
| -33% | -$683K |
|
Similar funds
Boston Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Boston Partners held 792 positions worth $67.9B, down 2.7% from $69.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2016 filing shows 60 new, 302 increased, 281 reduced and 78 closed positions. Its largest new stake was Pultegroup: 16,274,531 shares worth $304M. The largest sale was Pfizer, an estimated $701M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q1 2016 buy was Pultegroup: 16,274,531 shares worth $304M.
- Boston Partners added most to Bank of America in Q1 2016, an estimated $761M increase.
- Boston Partners's biggest Q1 2016 reduction was Pfizer, cutting an estimated $701M.
- Boston Partners fully exited TOWERS WATSON & CO COM STK CL A (DE) in Q1 2016, selling an estimated $286M.
- Boston Partners's ten largest holdings make up 17% of its $67.9B portfolio in Q1 2016.
- Boston Partners opened 60 new positions and closed 78 in Q1 2016.
- Boston Partners's portfolio value fell 2.7% quarter-over-quarter to $67.9B.
Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.